111 HUNTINGTON AVENUE,
BOSTON , MA, 02199
BOSTON , MA, 02199
Summary
The fund seeks capital appreciation by investing in companies across any size in the United States.
The investment process is designed to highlight companies that exhibit above average earnings growth potential. The process also focuses on undervalued companies that are trading at a discount to their estimated intrinsic value.
The research team combines fundamental and quantitative analysis to evaluate potential individual More
Link
Directors
Nov 13, 2023- Laurie J. Thomsen
- Peter D. Jones
- John P. Kavanaugh
- Michael W. Roberge
- Maryanne L. Roepke
- Clarence Otis, Jr.
- Maureen R. Goldfarb
- James W. Kilman, Jr.
- Steven E. Buller
- John A. Caroselli
Chief Compliance Officer
- Rosa E. Licea-Mailloux
Fund Manager(s)
- Joseph MacDougall
Price
- 52-Week High/Low
- $57.06 - $45.81
- Turnover
- 29%
- Expense Ratio
- 0.92%
Company Name |
Holding |
| Johnson & Johnson | 1.34 % |
| AbbVie Inc | 1.31 % |
| Salesforce Inc | 1.07 % |
| Dun & Bradstreet Holdings Inc | 0.92 % |
| Vertex Pharmaceuticals Inc | 0.87 % |
| Chubb Ltd | 0.79 % |
| PNC Financial Services Group Inc/The | 0.59 % |
| Wells Fargo & Co | 0.58 % |
| Mondelez International Inc | 0.55 % |
| Amphenol Corp | 0.51 % |
| More | 0.51 % |
Documents
Performance
YTD
-
3 Year
39.27%
5 Year
47.62%
Best
34.1%
2013
Worst
-37.87%
2008
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | 10.3% | 5.6% | -5.9% | 5.8% | -19% | 14.5% | 0.1% | 6.7% | 0.4% |
| Q2 | - | -2.5% | 7.8% | -14.1% | 8.4% | 20.4% | 4.3% | 6.1% | 4.7% | 2.8% |
| Q3 | - | - | -3.8% | -4.5% | -6.5% | 6.6% | 0.6% | 6.4% | 4.9% | 4.1% |
| Q4 | - | - | 9.5% | 3.4% | 8.6% | 12.3% | 6.4% | -13.8% | 5.7% | 3.4% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | 1.1% | 5.7% | 3.3% | -2.7% | - | - | - | - | - | - | - | - |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 7% | 20% | -20% | 17% | 17% | 30% | -4% | 24% | 11% |
Alpha
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| MRGHX | - | 7% | 20% | -20% | 17% | 17% | 30% | -4% | 24% | 11% |
| Russell 3000 Index | - | - | - | -21% | 24% | 19% | 29% | -7% | 19% | 10% |
| Alpha | - | 7% | 20% | 1% | -8% | -2% | 2% | 3% | 6% | 1% |